Trellus Health Reports FY 2024 Results: J&J Partnership Amid Going Concern Warning

• Revenue: $114k (2023: $19k). YTD 2025 contracted revenue is $340k – better, but still a drop in a $7.2m loss bucket.
• Losses: Adjusted EBITDA loss widened to $7.2m (2023: $5.8m loss). Basic loss per share: -$0.05.
• Cash: $4.3m at year-end → $2.5m by April 2025. Runway ends October 2025 based on current contracts only.

The brutal truth? Their survival hinges on either:

• Converting pilot deals (like J&J) into substantial, recurring revenue streams fast.
• Securing new funding (equity/debt/partnership cash) well before Halloween 2025.

The “Going Concern” Elephant in the Room

Let’s be blunt: Auditors don’t slap this label lightly. The wording is stark:

“There is no guarantee that sufficient cash inflows… will be forthcoming… This represents a material uncertainty… which may result in the Company… not being a going concern.”

Directors are “evaluating all commercial options” and “discussing fundraising.” Translation: They’re actively hawking the story to investors or potential acquirers. Failure means asset sales or liquidation. It’s binary – significant dilution or oblivion.

Leadership’s Gambit: Confidence vs. Clock

Dubinsky projects steely resolve: “We continue to allocate resources thoughtfully… advancing partnership discussions.” Chairman Murphy talks of “expanded pipeline” and “commercial traction.” The optimism centres entirely on the J&J deal proving their tech’s value – fast enough to attract a lifeline.

The Investor Takeaway: High Stakes, Higher Risk

Trellus sits at a crossroads:

• The Bull Case: J&J pilot delivers knockout data → J&J or another pharma commits serious cash → Trellus becomes a vital adherence/resilience tool embedded in therapy programs → Share price moonshot.
• The Bear Case: J&J data is lukewarm/comes too late → Funding talks stall → Cash runs dry → Administration or fire-sale. Existing shares could be wiped out.

Watch closely: Updates on J&J pilot enrolment/results, any new funding announcements (terms matter!), and Q3 cash burn figures. This is a binary trade playing out in real-time. The tech has merit, but the clock is ticking louder than any revenue stream right now. Proceed with extreme caution – and only with money you can afford to light on fire.